D. Venter

发表

A novel nicastrin mutation in a three‐generation Dutch family with hidradenitis suppurativa: a search for functional significance

A. Vossen, K. R. van Straalen, S. Swagemakers, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Chips with everything: DNA microarrays in infectious diseases.

D. Venter, N. Curtis, P. Bryant, 2004, The Lancet. Infectious diseases.

De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation.

G. Giles, J. Hopper, M. Southey, 1999, American journal of human genetics.

Comparison of DNA‐ and RNA‐Based Methods for Detection of Truncating BRCA1 Mutations

A. Whittemore, J. Hopper, M. Southey, 2002, Human mutation.

Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.

John L Hopper, Gillian S Dite, Graham G Giles, 2003, Journal of the National Cancer Institute.

Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis

Benjamin Tang, Anthony McLean, Deon Venter, 2011, Critical care.

The role of defensive ecological interactions in the evolution of conotoxins

R. Lewis, D. Venter, P. Alewood, 2016, Molecular ecology.

Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.

G. Giles, M. Southey, D. Easton, 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

CFTR deltaF508 carrier status, risk of breast cancer before the age of 40 and histological grading in a population-based case-control study.

G. Giles, M. McCredie, G. Dite, 1998, International journal of cancer.

The pathology of inherited breast cancer

D. Venter, J. Armes, 2002, Pathology.

Production and characterization of monoclonal antibodies to the c-erbB-2 proto-oncogene protein using a synthetic peptide immunogen.

W. Gullick, D. Venter, C. Dean, 1988, Biochemical Society transactions.

Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients.

M. Southey, G. Birrell, J. Ramsay, 2000, International journal of radiation oncology, biology, physics.

Retinoblastoma gene deletions in human glioblastomas.

M. Noble, R. Ludwig, T. Riley, 1991, Oncogene.

Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers

K. Gish, Wee-Kheng Soo, D. Venter, 2004, Oncogene.

Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs.

I. Kola, L. Jermiin, J. Drago, 2001, Genome research.

Squamous cell carcinoma of the tongue in a child with Fanconi anemia: a case report and review of the literature.

S. Garland, D. Venter, S. Tabrizi, 1995, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association.

A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts

T. van der Poll, M. Bonten, B. Scicluna, 2015, PLoS medicine.

Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status

G. Giles, M. McCredie, G. Dite, 2003, British Journal of Cancer.

Characterization of a t(8;13)(p11;q11‐12) in an atypical myeloproliferative disorder

D. Smedley, C. Cooper, J. Shipley, 1998, Genes, chromosomes & cancer.

Advances in Brief Stanniocalcin 2 Is an Estrogen-responsive Gene Coexpressed with the Estrogen Receptor in Human Breast Cancer 1

M. Southey, R. Reddel, D. Venter, 2002 .

Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell lines.

M. de Silva, D. Venter, S. Ramus, 2005, Cancer genetics and cytogenetics.

Molecular genetic study showing that the IN/157 ‘oligodendroglioma’ cell line has been contaminated by rhabdomyosarcoma (RD) cells

M. Noble, D. Venter, M. Strattons, 1992, Neuropathology and applied neurobiology.

Chromosomal Fragile Site FRA 16 D and DNA Instability in Cancer 1

R. Richards, M. Mangelsdorf, L. Hobson, 2000 .

Abnormalities of the RB1 Pathway in Ovarian Serous Papillary Carcinoma as Determined by Overexpression of the p16(INK4A) Protein

M. de Silva, D. Venter, J. Armes, 2005, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

High resolution spatial mapping of brominated pyrrole-2-aminoimidazole alkaloids distributions in the marine sponge Stylissa flabellata via MALDI-mass spectrometry imaging.

A. Carroll, D. Venter, Jennifer Yarnold, 2012, Molecular bioSystems.

The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.

G. Giles, J. Hopper, A. Spurdle, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Common chromosomal fragile site FRA16D mutation in cancer cells.

K. Friend, G. Chenevix-Trench, R. Richards, 2005, Human molecular genetics.

Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu.

M. Southey, D. Venter, T. Bouras, 2001, Cancer research.

Isolated Ventricular Noncompaction Cardiomyopathy Presenting as Fetal Hydrops at 24 Weeks Gestation

Andrew P. Stubbs, P. J. van der Spek, D. Venter, 2016, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

Molecular analysis in the diagnosis of pediatric lymphomas.

M. Southey, D. Venter, C. Chow, 1996, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association.

Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells.

K. Atkinson, D. Venter, K. Gilshenan, 2008, Stem cells and development.

Effects of backbone cyclization on the pharmacokinetics and drug ef ﬁ ciency of the orally active analgesic conotoxin cVc1.1 in Drug

D. Craik, T. Durek, D. Venter, 2021 .

The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations

G. Giles, J. Hopper, M. Southey, 1998, Cancer.

Phenotype‐directed analysis of genotype in early‐onset, familial breast cancers

E. Provenzano, T. Cowie, D. Venter, 2006, Pathology.

Distinct roles for Toll and autophagy pathways in double-stranded RNA toxicity in a Drosophila model of expanded repeat neurodegenerative diseases.

R. Richards, S. E. Samaraweera, L. O'Keefe, 2013, Human molecular genetics.

Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial.

M. McGuckin, D. Venter, S. Taylor, 2016, Annals of the American Thoracic Society.

Molecular cloning and sequencing of a novel human P2 nucleotide receptor.

M. Southey, D. Venter, G. Somers, 1996, Biochimica et biophysica acta.

The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.

G. Giles, A. Spurdle, G. Chenevix-Trench, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Hypermethylation of the inhibin alpha-subunit gene in prostate carcinoma.

J. F. Schmitt, M. Frydenberg, D. Millar, 2002, Molecular endocrinology.

Multiple leiomyosarcomas of both donor and recipient origin arising in a heart-lung transplant patient.

D. Venter, C. Robertson, C. Chow, 1998, The American journal of surgical pathology.

Immunohistochemical localization of c-erbB-2 in human breast carcinomas.

B. Gusterson, W. Gullick, S. Ashley, 1987, Molecular and cellular probes.

The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years.

Cellular and Molecular Approaches to the Study of Gliomas and Glial Development

M. Noble, D. Venter, K. Bevan, 1995 .

After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.

G. Giles, J. Hopper, M. Southey, 2001, American journal of human genetics.

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

M. Stratton, M. J. van de Vijver, J. Chang-Claude, 1998, Journal of the National Cancer Institute.

CYP17 promoter polymorphism and breast cancer in Australian women under age forty years.

G. Giles, A. Spurdle, D. Easton, 2000, Journal of the National Cancer Institute.

Inosine Triphosphate Pyrophosphohydrolase (ITPA) polymorphic sequence variants in adult hematological malignancy patients and possible association with mitochondrial DNA defects

Robert W. Taylor, M. Zamzami, T. Florin, 2013, Journal of Hematology & Oncology.

Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice

M. Tymms, I. Kola, T. Wilson, 1996, Nature.

Use of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry To Identify Vancomycin-Resistant Enterococci and Investigate the Epidemiology of an Outbreak

D. Venter, B. Hamilton, P. Griffin, 2012, Journal of Clinical Microbiology.

Searching for candidate genes for male infertility.

E. Moses, D. Venter, J. Armes, 2003, Asian journal of andrology.

OVEREXPRESSION OF THE c-erbB-2 ONCOPROTEIN IN HUMAN BREAST CARCINOMAS: IMMUNOHISTOLOGICAL ASSESSMENT CORRELATES WITH GENE AMPLIFICATION

W. Gullick, D. Venter, Sanjeev Kumar, 1987, The Lancet.

The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2.

M. Stratton, M. J. van de Vijver, J. Chang-Claude, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.

G. Giles, J. Hopper, M. Southey, 1999, Cancer research.

The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer

Norman Boyd, John L Hopper, Irene L Andrulis, 2004, Breast Cancer Research.

Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types.

D. Bowtell, A. Kilian, P. Keese, 1997, Human molecular genetics.

L1 Retrotransposon Heterogeneity in Ovarian Tumor Cell Evolution.

G. Faulkner, A. Ewing, Patricia E. Carreira, 2018, Cell reports.

The LIM domain gene LMO4 inhibits differentiation of mammary epithelial cells in vitro and is overexpressed in breast cancer

J. Visvader, E. Sum, G. Lindeman, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-MYB.

R. Ramsay, D. Venter, R. Freeman, 2000, Cancer research.

The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.

D. Smedley, C. Cooper, J. Clark, 1998, Human molecular genetics.

A point mutation in the pre-ZRS disrupts sonic hedgehog expression in the limb bud and results in triphalangeal thumb–polysyndactyly syndrome

N. Ahituv, P. J. van der Spek, A. de Klein, 2018, Genetics in Medicine.

Growth control in normal cells and in relation to carcinogenesis

W. Gullick, D. Venter, 1987 .

Chromosomal fragile site FRA16D and DNA instability in cancer.

R. Richards, M. Mangelsdorf, L. Hobson, 2000, Cancer research.

Evolution of separate predation- and defence-evoked venoms in carnivorous cone snails

I. Vetter, A. Antunes, R. Lewis, 2014, Nature Communications.

Coexistent T-cell lymphoblastic lymphoma and an atypical myeloproliferative disorder associated with t(8;13)(p21;q14).

M. Southey, S. Rockman, D. Venter, 1997, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association.

Adaptive evolution of the tumour suppressor BRCA1 in humans and chimpanzees

Simon Easteal, Gavin A. Huttley, Graham G. Giles, 2000, Nature Genetics.

Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients.

M. Southey, H. Elsaleh, D. Venter, 2001, International journal of radiation oncology, biology, physics.

Multiple sequential molecular abnormalities in the evolution of human gliomas.

D. Thomas, D. Venter, DJ Venter, 1991, British Journal of Cancer.

Tissue Hyperplasia and Enhanced T-Cell Signalling via ZAP-70 in c-Cbl-Deficient Mice

D. Bowtell, L. Barnett, W. Langdon, 1998, Molecular and Cellular Biology.

c-Myb is critical for murine colon development

R. Ramsay, D. Venter, M. Mucenski, 1999, Oncogene.

Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation

P. Angus, D. Venter, B. Ross, 1994, Cancer.

Germline RET codon 918 mutation in apparently isolated intestinal ganglioneuromatosis.

B. Ponder, M. Southey, M. Patton, 1998, The Journal of clinical endocrinology and metabolism.

Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)

S. Fisher, C. Lewis, L. Andrews, 2003, Breast Cancer Research.

Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS).

G. Giles, G. Chenevix-Trench, G. Dite, 1999, Journal of the National Cancer Institute. Monographs.

Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population‐based study

G. Giles, J. Hopper, E. Provenzano, 2004, Pathology.

CFTR ΔF508 carrier status, risk of breast cancer before the age of 40 and histological grading in a population‐based case‐control study

G. Giles, J. Hopper, M. Southey, 1998 .

Application of Whole Genome Sequencing Technology in the Investigation of Genetic Causes of Fetal, Perinatal, and Early Infant Death

Andrew P. Stubbs, R. Tearle, P. J. van der Spek, 2018, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

Tissue microarrays: a practical guide.

Beena Kumar, D. Venter, Deon J Venter, 2004, Pathology.

Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years.

G. Giles, A. Spurdle, M. Southey, 1999, Journal of the National Cancer Institute.

Molecular Pathologic Analysis Enhances the Diagnosis and Management of Muir-Torre Syndrome and Gives Insight Into Its Underlying Molecular Pathogenesis

M. Southey, K. Aittomäki, M. Young, 2001, The American journal of surgical pathology.

Sialin, an anion transporter defective in sialic acid storage diseases, shows highly variable expression in adult mouse brain, and is developmentally regulated

Andrew P. Stubbs, C. Masters, G. Mancini, 2005, Neurobiology of Disease.

Rapid Diagnosis of Germline p53 Mutation Using the Enzyme Mismatch Cleavage Method

B. Kemper, R. Cotton, D. Venter, 1996, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer.

Deon Venter, K. Gish, K. Kwok, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Biochemical Modulation of Venom by Spiders is Achieved Via Compartmentalized Toxin Production and Storage

B. Haas, K. Clauser, D. Korbie, 2019, SSRN Electronic Journal.

Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast.

G. Giles, J. Hopper, E. Provenzano, 2003, European journal of cancer.

Differential diagnosis of serous papillary carcinoma of the gynaecological tract and basal breast carcinoma: an immunohistochemical approach

D. Venter, J. Armes, R. Lourie, 2010, Pathology.

Regressive logistic and proportional hazards disease models for within‐family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer

G. Giles, A. Spurdle, M. Southey, 2003, Genetic epidemiology.

Hypermethylation of the Inhibin α-Subunit Gene in Prostate Carcinoma

M. Frydenberg, D. Millar, P. Molloy, 2002 .

Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer.

Melissa C Southey, M. Southey, R. Reddel, 2002, Cancer research.

Production and packaging of a biological arsenal: Evolution of centipede venoms under morphological constraint

N. Kurniawan, D. Merritt, G. King, 2015, Proceedings of the National Academy of Sciences.

Perturbation of the Akt/Gsk3-β signalling pathway is common to Drosophila expressing expanded untranslated CAG, CUG and AUUCU repeat RNAs

R. Richards, S. E. Samaraweera, L. O'Keefe, 2011, Human molecular genetics.

EWS/FLI-1 fusion transcript detection and MIC2 immunohistochemical staining in the diagnosis of Ewing's sarcoma.

M. Southey, D. Venter, C. Chow, 1996, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association.

Primary cutaneous Ewing's sarcoma/peripheral primitive neuroectodermal tumors in childhood. A molecular, cytogenetic, and immunohistochemical study.

M. Southey, D. Venter, C. Chow, 1995, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Profiling COVID-19 Genetic Research: A Data-Driven Study Utilizing Intelligent Bibliometrics

Jie Lu, Yi Zhang, Mengjia Wu, 2021, Frontiers in Research Metrics and Analytics.

Estrogen receptor polymorphism at codon 325 and risk of breast cancer in women before age forty.

G. Giles, M. Southey, G. Dite, 1998, Journal of the National Cancer Institute.

Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status

G. Giles, M. Southey, G. Dite, 2003, British Journal of Cancer.

HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years.

G. Giles, M. Southey, G. Dite, 1999, Journal of the National Cancer Institute.

First outbreak of PVL-positive nonmultiresistant MRSA in a neonatal ICU in Australia: comparison of MALDI-TOF and SNP-plus-binary gene typing

D. Venter, G. Nimmo, M. Tilse, 2010, European Journal of Clinical Microbiology & Infectious Diseases.

Chromosomal localization of the human P2y6 purinoceptor gene and phylogenetic analysis of the P2y purinoceptor family.

M. Southey, R. Richards, D. Venter, 1997, Genomics.

BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer

G. Giles, R. Osborne, G. Dite, 1999, British Journal of Cancer.

After hMSH2 and hMLH1—what next? Analysis of three‐generational, population‐based, early‐onset colorectal cancer families

D. Bishop, G. Giles, M. Southey, 2002, International journal of cancer.

Expression of the P2Y6 purinergic receptor in human T cells infiltrating inflammatory bowel disease.

M. Southey, D. Venter, G. Somers, 1998, Laboratory investigation; a journal of technical methods and pathology.

A specific GFP expression assay, penetrance estimate, and histological assessment for a putative splice site mutation in BRCA1

M. Southey, M. Jenkins, M. Young, 2003, Human mutation.

DNA extraction from placental, fetal and neonatal tissue at autopsy: what organ to sample for DNA in the genomic era?

D. Venter, J. Harraway, J. Armes, 2019, Pathology.

Molecular cloning and sequencing of the gene encoding a sheep arginine vasopressin type 1a receptor.

C. Johnston, D. Venter, P. Phillips, 1995, Biochimica et biophysica acta.

Drosophila orthologue of WWOX, the chromosomal fragile site FRA16D tumour suppressor gene, functions in aerobic metabolism and regulates reactive oxygen species

R. Richards, A. Choo, D. Venter, 2010, Human molecular genetics.

Ovarian Microcystic Stromal Tumor: A Rare Clinical Manifestation of Familial Adenomatous Polyposis

D. Venter, J. Harraway, J. Armes, 2016, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Multifunctional warheads: diversification of the toxin arsenal of centipedes via novel multidomain transcripts.

K. Sunagar, D. Venter, E. Undheim, 2014, Journal of proteomics.

Effects of backbone cyclization on the pharmacokinetics and drug efficiency of the orally active analgesic conotoxin cVc1.1

David M. Shackleford, D. Craik, T. Durek, 2021 .

Detailed gene copy number and RNA expression analysis of the 17q12–23 region in primary breast cancers

K. Gish, P. J. van der Spek, Wee-Kheng Soo, 2003, Genes, chromosomes & cancer.

Functional Analysis of Genetic Variation in the SECIS Element of Thyroid Hormone Activating Type 2 Deiodinase.

P. Larsen, W. Klootwijk, P. J. van der Spek, 2018, The Journal of clinical endocrinology and metabolism.

Expression of the human P2Y6 nucleotide receptor in normal placenta and gestational trophoblastic disease.

A. Conigrave, D. Venter, G. Somers, 1999, Laboratory investigation; a journal of technical methods and pathology.

Genome-wide association study identifies novel breast cancer susceptibility loci

Lester L. Peters, A. Uitterlinden, D. Cox, 2007, Nature.